Abstract:International guidelines from public health organizations, including the World Health Organization, caution against graded exercise for treating patients with postexertional symptom exacerbation (PESE), a commonly reported feature of post–COVID-19 condition (PCC). These recommendations are provided despite the well-documented deleterious effects of physical inactivity and its close association with secondary health conditions and deterioration in quality of life. Subsequently, there has been confusion and reluctance among health care practitioners to prescribe exercise-based rehabilitation to individuals with PCC to avoid the debilitating effects of postexertional malaise, fatigue, or PESE. Consequently, the effects of exercise-based rehabilitation for individuals with persistent PESE remain poorly understood. Studies have shown that among individuals with PCC, up to 48% of female individuals and 41% of male individuals experience postexertional malaise, and 29% of female individuals and 28% of male individuals experience orthostatic intolerance. 1 The article by Tryfonos and colleagues 2 is, therefore, timely and necessary because it addresses an important topic in the debate surrounding patient acceptability and the therapeutic effects of different exercise modalities in the treatment of patients with PCC and their acute risks of developing PESE. Tryfonos et al 2 recruited 31 nonhospitalized, community-based participants with a mean (SD) symptom duration of 21.6 (9.2) months following COVID-19 illness (with 31 age-matched and sex-matched healthy controls for comparison). This previously healthy and working-age population represents an important section of society; 78% of the PCC group were employed full-time before SARS-CoV-2 infection. Subsequently, 74% had to take sick leave lasting longer than 12 months. PCC, therefore, has a substantial economic impact on nonhospitalized, working-aged individuals, a challenge that is magnified if job roles are cognitively and/or physically demanding. 3 The careful introduction and future management of exercise therapy in the treatment of individuals with postviral conditions has been previously proposed following a comprehensive needs analysis to mitigate PESE. 4 This can be achieved by individually tailoring exercise prescription and/or management and incorporating both resistance exercise and cardiorespiratory fitness, in an approach termed symptom-guided exercise rehabilitation . 4 Testing this theory, Tryfonos and colleagues 2 monitored the acute effects of 3 different types of exercise stimulus in those with PESE, compared with healthy controls, aware that patients with PCC spent 43% less time in moderate-to-vigorous physical activity compared with controls (approximately 26.5 minutes per day). The 3 exercise modalities were (1) high-intensity interval training (HIIT), (2) moderate-intensity continuous training (MICT), and strength-based training (ST) performed in a randomized, crossover design with 2 to 4 weeks of washout between sessions. The primary outcome measure was the difference in fatigue level (from baseline to 48 hours after exercise) between groups. The authors chose this time, citing that those with phenotypically similar myalgic encephalomyelitis–chronic fatigue syndrome commonly report PESE between 24 and 72 hours after exertion. Reassuringly, there were no between-group differences in fatigue 48 hours after any exercise modality (HIIT, MICT, or ST). However, subtle differences in self-reported symptoms were observed following each exercise condition, with patients with PCC reporting higher levels of concentration impairment following MICT and greater increases in muscle soreness after ST (commensurate with delayed onset of muscle soreness, which is expected after completing unfamiliar loaded resistance exercise). Compared with healthy controls, the PCC group had higher overall self-reported symptom scores at all time points (before exercise, immediately after exercise, and at 48 hours follow-up) alongside substantial physiological characteristics; indeed, a particular strength of this study 2 is the range of physiological assessments undertaken. The PCC group demonstrated underlying dysfunction in multiple organ systems that may contribute to activity limitations, including muscular impairment (ie, higher incidence of myogenic-derived myopathies observed alongside decreased isometric muscle strength), indices of orthostatic intolerance, lower peak and submaximal aerobic capacity (ie, maximal oxygen consumption at peak and ventilatory threshold), lower heart rate variability (recorded during deep breathing), higher resting heart rate, and increased arterial stiffness. Tryfonos et al 2 proposed mechanisms, including physical inactivity, peripheral tissue damage, and/or neurophysiological changes, for these -Abstract Truncated-

Non‐Hospitalized Patients With Post‐COVID Condition and Myopathic Electromyography Findings Show no Difference in Symptom Severity and Clinical Manifestations Compared to Those Without Myopathic Findings

Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology

Quantitative muscle magnetic resonance imaging depicts microstructural abnormalities but no signs of inflammation or dystrophy in post-COVID-19 condition

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic

Myopathy as a cause of fatigue in long‐term post‐COVID‐19 symptoms: Evidence of skeletal muscle histopathology

Exercise Intolerance in Patients With Post-COVID Condition

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms

Analysis of Post COVID-19 Condition and Its Overlap with Myalgic Encephalomyelitis/chronic Fatigue Syndrome.

A review of cytokine-based pathophysiology of Long COVID symptoms

Investigating the Profile of Patients with Idiopathic Inflammatory Myopathies in the Post-COVID-19 Period: Emphasizing Myocardial Injury

Characteristics of Peripheral Neuropathy in Post-COVID-19 Condition Population: A One Year Prospective Cohort Study Based on Electrophysiological Assessment

Post-SARS-CoV-2 Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms in Two Cohort Studies of COVID-19 Recovery

Exercise Therapy for Post–COVID-19 Condition

High Somatization Rates, Frequent Spontaneous Recovery, and a Lack of Organic Biomarkers in Post‐Covid‐19 Condition

Impaired Hand Grip Strength Correlates with Greater Disability and Symptom Severity in Post-COVID Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Post–COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clinic and Characteristics of the Initial Patient Cohort

Cardiopulmonary exercise testing in long covid shows the presence of dysautonomia or chronotropic incompetence independent of subjective exercise intolerance and fatigue

Muscle abnormalities worsen after post-exertional malaise in long COVID

Persistent Fatigue, Weakness, and Aberrant Muscle Mitochondria in Survivors of Critical COVID-19

Repeated Hand Grip Strength is an Objective Marker for Disability and Severity of Key Symptoms in Post-COVID ME/CFS

Ebbing Strength, Fading Power: Unveiling the Impact of Persistent Fatigue on Muscle Performance in COVID-19 Survivors